GBP3, though less broadly prognostic, promotes glioblastoma growth when overexpressed, activating pathways such as p62-ERK1/2 to fuel proliferation and resistance, with minimal impact on other cancers’ outcomes [32,53]. This evidence concerns the gene MAPK3 and glioblastoma.